Patricia Industries' Advanced Instruments Acquires Nova Biomedical
March 19, 2025
Advanced Instruments, a subsidiary of Patricia Industries, has acquired Nova Biomedical for an enterprise value of USD 2.2 billion. The combined business will operate under the Nova Biomedical name, be led by Advanced Instruments CEO Byron Selman, and creates a diversified global life-science tools platform serving biopharmaceutical and clinical markets.
- Buyers
- Advanced Instruments, Patricia Industries
- Targets
- Nova Biomedical
- Sellers
- Founding shareholders of Nova Biomedical, Frank Manganaro, Dr. Chung-Chang Young
- Platforms
- Advanced Instruments
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Patricia Industries Acquires Advanced Instruments
September 28, 2020
Medical Devices
Patricia Industries, part of Investor AB, has completed the acquisition of US-based Advanced Instruments, a global leader in osmolality testing instrumentation and consumables, from Windjammer Capital. The deal values Advanced Instruments at an enterprise value of USD 780 million; Patricia Industries injected roughly USD 619–620 million of equity for majority ownership. Advanced Instruments (headquartered in Norwood, Massachusetts) serves clinical, biopharmaceutical and food & beverage markets and reported approximately USD 72 million in sales for the 12 months ending June 30, 2020.
-
Patricia Industries (Investor AB) Acquires Advanced Instruments from Windjammer Capital
September 1, 2020
Medical Devices
Patricia Industries, part of Investor AB, has signed an agreement to acquire Advanced Instruments, LLC from Windjammer Capital for an enterprise value of $780 million. Advanced Instruments, headquartered in Norwood, Massachusetts, is a manufacturer of scientific and analytical instruments serving the clinical, biotechnology and food & beverage markets; the transaction is expected to close in Q4 2020 subject to regulatory approvals.
-
Advanced Instruments Acquires Solentim
August 5, 2021
Medical Devices
Advanced Instruments has signed a definitive agreement to acquire Solentim for approximately USD 240 million, in a strategic add-on funded mainly with equity from Patricia Industries. The acquisition expands Advanced Instruments' bioprocessing instruments and consumables portfolio and combines complementary imaging, automation and single-cell cloning capabilities; Solentim is headquartered in Bournemouth, United Kingdom, and reported ~USD 17m revenue and ~USD 5m adjusted EBITDA for the 12 months to June 2021.
-
Advanced Instruments Acquires Artel
April 26, 2022
Medical Devices
Advanced Instruments has signed an agreement to acquire Artel, a Westbrook, Maine-based provider of calibration and validation instruments, consumables, software and services for life-science laboratories. The add-on transaction is funded by Patricia Industries and Advanced Instruments (with external debt), values Artel at an upfront ~$85m with contingent payments of up to $55m, and is intended to expand Advanced Instruments' liquid-handling portfolio and R&D capabilities.
-
Danaher Acquires Precision NanoSystems
June 1, 2021
Biotechnology
Danaher Corporation has acquired Vancouver-based Precision NanoSystems (PNI), a developer of lipid nanoparticle delivery technologies and microfluidic manufacturing platforms for genetic medicines. PNI will join Danaher's Life Sciences platform to expand its capabilities in mRNA and genetic-medicine development and complement existing portfolio companies such as Cytiva and Pall.
-
Aspen Medical Products Acquires Advanced Orthopaedics
January 29, 2025
Medical Devices
Aspen Medical Products, the Irvine-based spinal orthopedics manufacturer, has acquired Advanced Orthopaedics, a manufacturer and supplier of bracing solutions and orthopedic soft goods. The acquisition expands Aspen’s product portfolio into the bracing and supports market and is intended to strengthen service to distributors, hospitals, DME suppliers and retail partners while enhancing Aspen’s global reach.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.